Outsourcing the viral clearance and viral testing studies has emerged as a promising alternative for most of the manufacturers. Despite being one of the crucial steps amongst all the steps involved in the production of biologics, this service is heavily outsourced in the biopharmaceutical industry. Currently, it is estimated that more than 70% of these services are employed by biopharmaceutical and pharmaceutical companies. Service providers across the globe offering this service are large players.
Of these, close to 80% players provide services for both, viral clearance and viral testing of different type of biologics. Of the players have established their facilities in Europe. Within this region, UK has the maximum number of facilities (over 21%), followed by Germany (more than 15%) and France (close to 10%). Patents have been filed / granted over last few years. Of these, over 40% patents are granted by organizations headquartered in the US whereas close to 25% patent applications are filed by organizations headquartered in China.
As projected by Roots Analysis, more than 55% of the share is captured by viral removal, in the viral clearance market. As projected by Roots Analysis, 40% of the share is captured by North America, in this market. Driven by the rising interest in research and development activities and the demand for the viral clearance and viral testing services, the future opportunities and growth associated with this market are anticipated to witness a noteworthy growth in the foreseen future. Specifically, in terms of end-users, the market is anticipated to be driven by biotechnology and pharmaceutical industry.
For additional details, please visit
https://www.rootsanalysis.com/blog/viral-clearance-and-viral-testing-services/ or email [email protected]
You may also be interested in the following titles:
- Smart Labels Market: Industry Trends and Global Forecasts, 2022-2035
- 4D Bioprinting Market : Industry Trends and Global Forecasts, 2022-2035
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
[email protected]
